We are live on ! Find out more
CBST

CUBIST PHARMACEUTICALS INC
CBST

Delisted

CBST was delisted on the 21st of January, 2015.

307 hedge funds and large institutions have $8B invested in CUBIST PHARMACEUTICALS INC in 2014 Q4 according to their latest regulatory filings, with 124 funds opening new positions, 66 increasing their positions, 90 reducing their positions, and 68 closing their positions.

New
Increased
Maintained
Reduced
Closed

483% more funds holding in top 10

Funds holding in top 10: 635 (+29)

82% more first-time investments, than exits

New positions opened: 124 | Existing positions closed: 68

51% more capital invested

Capital invested by funds: $5.31B → $8B (+$2.69B)

21% more funds holding

Funds holding: 254307 (+53)

27% less repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 90

54% less call options, than puts

Call options by funds: $329M | Put options by funds: $708M

Holders
307
Holders Change
+53
Holders Change %
+20.87%
% of All Funds
8.19%
Holding in Top 10
35
Holding in Top 10 Change
+29
Holding in Top 10 Change %
+483.33%
% of All Funds
0.93%
New
124
Increased
66
Reduced
90
Closed
68
Calls
$329M
Puts
$708M
Net Calls
-$379M
Net Calls Change
-$371M
Name Holding Trade Value Shares
Change
Change in
Stake
PCM
326
Penn Capital Management
Pennsylvania
-$6.88M -103,635 Closed
IGIM
327
I.G. Investment Management
Manitoba, Canada
-$6.54M -98,602 Closed
ACMM
328
Arbor Capital Management (Minnesota)
Minnesota
-$6.29M -94,828 Closed
CGI
329
CI Global Investments
California
-$4.98M -75,000 Closed
Nordea Investment Management
330
Nordea Investment Management
Sweden
-$3.86M -58,140 Closed
AC
331
Apex Capital
California
-$3.78M -57,000 Closed
Jacobs Levy Equity Management
332
Jacobs Levy Equity Management
New Jersey
-$3.59M -54,080 Closed
MCM
333
Mazama Capital Management
Oregon
-$3.47M -52,362 Closed
ACM
334
Advent Capital Management
New York
-$4.03M -51,774 Closed
SIA
335
Sit Investment Associates
Minnesota
-$3.13M -47,175 Closed
IAM
336
Impax Asset Management
New Hampshire
-$3.03M -45,718 Closed
WMSA
337
Weiss Multi-Strategy Advisers
New York
-$2.98M -45,000 Closed
WA
338
Whitebox Advisors
Minnesota
-$2.82M -42,500 Closed
FRM
339
Fore Research & Management
New York
-$2.51M -37,900 Closed
3NC
340
300 North Capital
California
-$2.25M -33,945 Closed
ARC
341
Absolute Return Capital
Massachusetts
-$2.24M -33,721 Closed
Nomura Holdings
342
Nomura Holdings
Japan
-$2.07M -31,116 Closed
Macquarie Group
343
Macquarie Group
Australia
-$1.99M -29,926 Closed
EAM
344
Eventide Asset Management
Massachusetts
-$1.92M -29,000 Closed
SIM
345
Spark Investment Management
New York
-$1.92M -28,900 Closed
Mackenzie Financial
346
Mackenzie Financial
Ontario, Canada
-$1.84M -27,800 Closed
SGH
347
Sivik Global Healthcare
Connecticut
-$1.66M -25,000 Closed
SLG
348
Stanley-Laman Group
Pennsylvania
-$1.03M -15,554 Closed
PP
349
PDT Partners
New York
-$985K -14,845 Closed
USAA
350
United Services Automobile Association
Texas
-$837K -12,613 Closed

CBST Hedge Fund Activity: Q4 2014 in Review

307 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in CUBIST PHARMACEUTICALS INC (CBST) for Q4 2014, worth a combined $8B — up 51% from $5.31B a quarter earlier.

Buyers outnumbered sellers: 124 funds opened new CBST positions and 68 closed out — a net gain of 56 holders — while 66 added to existing stakes and 90 trimmed.

The largest buyer was HBK Investments, opening a new position worth an estimated $222M. The largest seller was Putnam Investments, cutting an estimated $477M.

  • 307 institutional investors held CUBIST PHARMACEUTICALS INC (CBST) as of Q4 2014, up from 254 in Q3 2014.
  • Funds reported $8B of CUBIST PHARMACEUTICALS INC stock for Q4 2014, up 51% quarter-over-quarter.
  • 124 funds opened new CUBIST PHARMACEUTICALS INC positions in Q4 2014 and 68 closed out, a net change of +56 holders.
  • The largest CUBIST PHARMACEUTICALS INC buyer in Q4 2014 was HBK Investments, an estimated $222M added.
  • The largest CUBIST PHARMACEUTICALS INC seller in Q4 2014 was Putnam Investments, an estimated $477M sold.

Based on aggregated 13F filings for Q4 2014.